Skip to main content

Table 7 Recorded Adverse Events

From: Pathogenetic approach to the treatment of functional disorders of the gastrointestinal tract and their intersection: results of the Russian observation retrospective program COMFORT

System organ class MedDRA

Disease

Number of AE

% of all patients

% of all AE

Total AE

94

0.65

100.00

N of patients who had at least 1 AE

80

0.55

 

Skin and subcutaneous tissue disorders

Erythema

1

0.007

 

Pruritus

6

0.04

 

Rash

1

0.007

 

Urticaria

2

0.01

 

N of AE in this group

10

0.06

10.63

N of patients who had at least 1 AE in this group

8

0.05

 

Musculoskeletal and connective tissue disorders

Myalgia

2

0.0139

 

N of AE in this group

2

0.0139

2.12

N of patients who had at least 1 AE in this group

2

0.0139

 

Nervous system disorders

Dizziness

3

0.02

 

Dysgeusia

2

0.01

 

Head discomfort

1

0.007

 

Headache

11

0.07

 

N of AE in this group

17

0.11

18.09

N of patients who had at least 1 AE in this group

15

0.10

 

Digestive system disorders

Abdominal distension

2

0.01

 

Abdominal pain

14

0.09

 

Abdominal pain upper

1

0.007

 

Anal pruritus

1

0.007

 

Constipation

4

0.02

 

Diarrhoea

2

0.01

 

Dyschezia

1

0.007

 

Dyspepsia

1

0.007

 

Epigastric discomfort

3

0.0209

 

Flatulence

1

0.007

 

Nausea

22

0.15

 

Tongue discomfort

3

0.02

 

N of AE in this group

55

0.38

58.51

N of patients who had at least 1 AE in this group

51

0.35

 

Cardiac disorders

Palpitations

1

0.007

 

N of AE in this group

1

0.007

1.06

N of patients who had at least 1 AE in this group

1

0.007

 

General disorders and administration site conditions

Asthenia

2

0.01

 

Drug ineffective

1

0.007

 

Feeling jittery

1

0.007

 

N of AE in this group

4

0.02

4.25

N of patients who had at least 1 AE in this group

3

0.02

 

Psychiatric disorders

Agitation

2

0.01

 

Sleep disorder

1

0.007

 

N of AE in this group

3

0.02

3.19

N of patients who had at least 1 AE in this group

2

0.01

 

Metabolism and nutrition disorders

Decreased appetite

1

0.007

 

Increased appetite

1

0.007

 

N of AE in this group

2

0.01

2.12

N of patients who had at least 1 AE in this group

2

0.01